Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype

Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1197-1204. doi: 10.1016/j.numecd.2019.06.012. Epub 2019 Jun 21.

Abstract

Background and aims: Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive hepatic fat accumulation. Increased hepatic saturated fats and decreased hepatic polyunsaturated fats may be particularly lipotoxic, contributing to metabolic dysfunction. We compared hepatic lipid subspecies in adults with and without NAFLD, and examined links with hallmark metabolic and clinical characteristics of NAFLD.

Methods and results: Nineteen adults with NAFLD (total hepatic fat:18.8 ± 0.1%) were compared to sixteen adults without NAFLD (total hepatic fat: 2.1 ± 0.01%). 1H-MRS was used to assess hepatic lipid subspecies. Methyl, allylic, methylene, and diallylic proton peaks were measured. Saturation, unsaturation, and polyunsaturation indices were calculated. Whole-body phenotyping in a subset of participants included insulin sensitivity (40 mU/m2 hyperinsulinemic-euglycemic clamps), CT-measured abdominal adipose tissue depots, exercise capacity, and serum lipid profiles. Participants with NAFLD exhibited more saturated and less unsaturated hepatic fat, accompanied by increased insulin resistance, total and visceral adiposity, triglycerides, and reduced exercise capacity compared to controls (all P < 0.05). All proton lipid peaks were related to insulin resistance and hypertriglyceridemia (P < 0.05).

Conclusion: Participants with NAFLD preferentially stored excess hepatic lipids as saturated fat, at the expense of unsaturated fat, compared to controls. This hepatic lipid profile was accompanied by an unhealthy metabolic phenotype.

Keywords: Insulin resistance; Magnetic resonance spectroscopy; Saturated fats.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Biomarkers / metabolism
  • Case-Control Studies
  • Cross-Sectional Studies
  • Dyslipidemias / diagnosis*
  • Dyslipidemias / metabolism
  • Dyslipidemias / physiopathology
  • Exercise Tolerance
  • Female
  • Humans
  • Insulin Resistance
  • Lipid Metabolism*
  • Lipidomics / methods*
  • Liver / metabolism*
  • Liver / physiopathology
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / diagnosis*
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Obesity, Abdominal
  • Phenotype
  • Predictive Value of Tests
  • Proton Magnetic Resonance Spectroscopy*

Substances

  • Biomarkers